These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 19248925)
41. Treatment of fragile X syndrome. Turk J Arch Dis Child; 1995 Jun; 72(6):544. PubMed ID: 7618950 [No Abstract] [Full Text] [Related]
42. Summary of the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Autism and other Pervasive Developmental Disorders. American Academy of Child and Adolescent Psychiatry. Volkmar F; Cook E; Pomeroy J; Realmuto G; Tanguay P J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1611-6. PubMed ID: 10596264 [TBL] [Abstract][Full Text] [Related]
43. Recent advances in research on early detection, causes, biology, and treatment of autism spectrum disorders. Dawson G Curr Opin Neurol; 2010 Apr; 23(2):95-6. PubMed ID: 20216345 [No Abstract] [Full Text] [Related]
44. [Considering on the type of ego structure with PDD from the viewpoint of relationship: in response to Hirosawa's paper "Pervasive developmental disorder in adults; importance of diagnosis in concern to the type of ego structure with PDD"]. Kobayashi R Seishin Shinkeigaku Zasshi; 2013; 115(3):253-60. PubMed ID: 23691811 [No Abstract] [Full Text] [Related]
45. Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions. Schwetye KE; Gutmann DH Expert Rev Neurother; 2014 Oct; 14(10):1139-52. PubMed ID: 25161109 [TBL] [Abstract][Full Text] [Related]
46. Treating Fragile X syndrome with the diuretic bumetanide: a case report. Lemonnier E; Robin G; Degrez C; Tyzio R; Grandgeorge M; Ben-Ari Y Acta Paediatr; 2013 Jun; 102(6):e288-90. PubMed ID: 23647528 [TBL] [Abstract][Full Text] [Related]
47. Possible basal ganglia pathology in children with complex symptoms. Yaryura-Tobias JA; Rabinowitz DC; Neziroglu F J Clin Psychiatry; 2003 Dec; 64(12):1495-501. PubMed ID: 14728112 [TBL] [Abstract][Full Text] [Related]
48. Cognitive behavioral therapy for early adolescents with autism spectrum disorders and clinical anxiety: a randomized, controlled trial. Wood JJ; Ehrenreich-May J; Alessandri M; Fujii C; Renno P; Laugeson E; Piacentini JC; De Nadai AS; Arnold E; Lewin AB; Murphy TK; Storch EA Behav Ther; 2015 Jan; 46(1):7-19. PubMed ID: 25526831 [TBL] [Abstract][Full Text] [Related]
49. [Left temporal arachnoid cyst and specific learning disorders associated with Pervasive Developmental Disorders - Not Otherwise Specified (PDD-NOS): contributions of an integrative neuropsychomotor, neuropsychological, psychopathological and neurosurgical approach about a case report in a child (François)]. Vaivre-Douret L; Boschi A; Cuny ML; Clouard C; Mosser A; Golse B; Philippe A; Bourgeois M; Boddaert N; Puget S Encephale; 2016 Dec; 42(6):582-588. PubMed ID: 27644917 [TBL] [Abstract][Full Text] [Related]
50. The presentation of anxiety in children with pervasive developmental disorders. Weisbrot DM; Gadow KD; DeVincent CJ; Pomeroy J J Child Adolesc Psychopharmacol; 2005 Jun; 15(3):477-96. PubMed ID: 16092912 [TBL] [Abstract][Full Text] [Related]
51. A case study in communication disorders. Patzer D; Grodberg D Child Adolesc Psychiatr Clin N Am; 1999 Jan; 8(1):175-88, viii. PubMed ID: 9894035 [TBL] [Abstract][Full Text] [Related]
52. Chain reaction or time bomb: a neuropsychiatric-developmental/neurodevelopmental formulation of tourettisms, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS. Kerbeshian J; Burd L; Tait A World J Biol Psychiatry; 2007; 8(3):201-7. PubMed ID: 17654411 [TBL] [Abstract][Full Text] [Related]
53. Co-occurring conditions and change in diagnosis in autism spectrum disorders. Close HA; Lee LC; Kaufmann CN; Zimmerman AW Pediatrics; 2012 Feb; 129(2):e305-16. PubMed ID: 22271695 [TBL] [Abstract][Full Text] [Related]
54. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. Aman MG; McDougle CJ; Scahill L; Handen B; Arnold LE; Johnson C; Stigler KA; Bearss K; Butter E; Swiezy NB; Sukhodolsky DD; Ramadan Y; Pozdol SL; Nikolov R; Lecavalier L; Kohn AE; Koenig K; Hollway JA; Korzekwa P; Gavaletz A; Mulick JA; Hall KL; Dziura J; Ritz L; Trollinger S; Yu S; Vitiello B; Wagner A; J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1143-54. PubMed ID: 19858761 [TBL] [Abstract][Full Text] [Related]
55. Diagnosis and evaluation of pervasive developmental disorders. Scahill L J Clin Psychiatry; 2005; 66 Suppl 10():19-25. PubMed ID: 16401146 [TBL] [Abstract][Full Text] [Related]
56. Autism spectrum disorders and epigenetics. Grafodatskaya D; Chung B; Szatmari P; Weksberg R J Am Acad Child Adolesc Psychiatry; 2010 Aug; 49(8):794-809. PubMed ID: 20643313 [TBL] [Abstract][Full Text] [Related]
57. Diagnostic yield of genetic testing in children diagnosed with autism spectrum disorders at a regional referral center. Roesser J Clin Pediatr (Phila); 2011 Sep; 50(9):834-43. PubMed ID: 21525079 [TBL] [Abstract][Full Text] [Related]
58. [Girls with fragile X syndrome: a model for specific developmental disorders]. Ferrando-Lucas MT; Puente-Ferreras A Rev Neurol; 2008; 46 Suppl 1():S17-9. PubMed ID: 18302115 [TBL] [Abstract][Full Text] [Related]
59. Measuring behaviour in developmental disability: a review of existing schedules. O'Brien G; Pearson J; Berney T; Barnard L Dev Med Child Neurol Suppl; 2001 Jul; 87():1-72. PubMed ID: 11468931 [No Abstract] [Full Text] [Related]
60. Intervention in the context of development: pathways toward new treatments. Veenstra-VanderWeele J; Warren Z Neuropsychopharmacology; 2015 Jan; 40(1):225-37. PubMed ID: 25182180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]